Latest filing published 13 Aug 2026 for AMGEN INC, €714k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Rachna Khosla is a declared insider of Amgen Inc (senior executive), with filings sourced from SEC (Form 4). Over a trading history stretching from 5 November 2021 to 13 August 2026, the count stands at 39 filings.
Sales make up the whole of the open-market record (5 sales, €1.9M). Besides market trades, the filings include 33 share grants and 1 option exercise. 2026 to date brings no purchases and 2 sales.
The record was last updated on 13 August 2026 with an open-market sale (€452k) in Amgen Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 39 declarations